Connect with us
Novartis is planning to buy U.S. East Coast biotechnology company The Medicines in New Jersey and close the transaction in 2020. Novartis has offered $85 per...
French government wants to focus on the development of new recycling techniques. Whether chemical or biotechnological, it will allow the return to the basic monomers of...
The microbiologist Elisabeth Mertl hopes to end animal testing for good. The scientist has developed tests that are arguably faster and more reliable than many tests...
Michelin aims to produce a new adhesive resin that does not contain materials that cause damage to the environment. Within the framework of the project, a...
Genfit announced results from a study demonstrating that NIS4, a non-invasive blood diagnostic tool developed for the diagnosis of non-alcoholic steatohepatitis (NASH), performed better than other...
The German company Gelita and the U.S. company Geltor are cooperating in the development of biotechnologically produced collagen proteins for the vegan food market. The two...
Investment in biopharmaceutical companies and the occurrence of chronic diseases are among the factors that play a role in the growth of the biologics market. Biopharmaceuticals...
The global slowdown in economic growth has so far left Roche and Novartis' businesses untouched. Both drug manufacturers, based in Basel, are currently growing significantly faster...
The US biotech group Biogen dares to make a new start with its Alzheimer's drug Aducanumab, the group plans to submit an application for approval in...
The publication of the results of the phase IIa clinical trial, evaluating ABX464 in hemorrhagic recto colitis, has been driving the stock market price of Montpellier...
 |
|
 |  |
 |
|